Open AccessTo analyze the role of intravenous tranexamic acid in hip fracture surgeries in orthopedic trauma
Author(s) -
Girish Sahni,
Monika Sood,
Deepak Girdhar,
Priya Sahni,
Ayush Jain,
Sanjeev Kumar
Publication year - 2021
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/ijabmr.ijabmr_638_20
Subject(s) - tranexamic acid , medicine , orthopedic surgery , group b , blood transfusion , surgery , anesthesia , hip fracture , total hip arthroplasty , randomized controlled trial , hemoglobin , placebo , group a , blood loss , osteoporosis , alternative medicine , pathology
Hip fractures in orthopedic trauma cases are increasing. Majority of such patients undergoing surgery require blood transfusion of one or more units. Intravenous (I. V.) Tranexamic acid (TXA) may decrease loss of blood, decrease need of blood transfusion, and improve postoperative hemoglobin (Hb) along with lesser adverse effects. Risk of thromboembolic phenomena remains a concern. A study was done to analyze the role of I. V. TXA in hip fracture surgeries in trauma cases.